Novel polymorphism in p21waf1/cip1 cyclin dependent kinase inhibitor gene: association with human esophageal cancer
Authors:
- Sonia AroraSASonia Arora
- Neera NathNNNeera Nath
- Meera MathurMMMeera Mathur
- Nootan K ShuklaNSNootan K Shukla
- Ranju RalhanRRRanju Ralhan
- 20 January 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (3) , 323-328
Abstract
P21(waf1/cip1), an important regulator of the cell cycle, binds to PCNA and acts as a mediator of the growth suppressing and apoptosis promoting functions of p53. We report a hitherto unobserved polymorphism in the carboxy terminal domain (codon 149) of p21(waf1/cip1) gene, the domain encoding the PCNA binding motif. The codon 149 polymorphism (GAT-->GGT) was observed in 42 of 50 (84%) esophageal squamous cell carcinomas (ESCCs) and eight of 50 (16%) normal individuals. The resultant amino acid substitution from aspartate to glycine may have vital implication in PCNA mediated cell cycle regulation by p21(waf1/cip1). The second polymorphism at codon 31, involving a C-->A transversion at nucleotide 168 (AGC-->AGA) changing the amino acid from serine to arginine, was observed in 2/50 (4%) ESCCs at a relatively lower frequency in the Indian population than that reported in the West. No significant association was observed between p21(wap1/cip1) polymorphism at codon 149 and p21(wap1/cip1) protein expression in ESCC in this cohort of patients. Interestingly, the frequency of p21(wap1/cip1) variants (codon 149) in ESCCs (18 of 19 cases) with wild-type p53 was significantly higher than in tumors with p53 mutations, suggesting that this polymorphism affects the p53 pathway and may play an important role in esophageal tumorigenesis. Analysis of p21(waf1/cip1) expression in relation to p53 gene and protein status revealed its induction by p53-dependent as well as independent pathways in esophageal tumorigenesis.Keywords
This publication has 22 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Book ReviewsDevelopment Policy Review, 1998
- Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNACell, 1996
- Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomasMelanoma Research, 1995
- Two variants of the CIP1/WAF1 gene occur together and are associated with human cancerHuman Molecular Genetics, 1995
- Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature, 1995
- Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repairNature, 1994
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Role of alcohol in cancers of the upper alimentary tract: use of models in risk assessment.Journal of Epidemiology and Community Health, 1988